Secondary Biliary Obstruction and Cirrhosis

Choose the test by the job

Finding dilation, mapping the cause, and draining the duct are three different tasks.

Transabdominal ultrasound is usually the first study for suspected obstruction because it detects gallstones, gallbladder pathology, and intrahepatic or extrahepatic duct dilation without radiation.

MRCP noninvasively maps the biliary tree and the level of a stone or stricture; EUS is especially useful for small distal stones or periampullary and pancreatic lesions.

ERCP is invasive and primarily therapeutic: it drains infected or symptomatic obstruction, extracts stones, dilates or stents strictures, and can obtain brushings or biopsy.

Ultrasound finds backup, MRCP maps it, and ERCP fixes it.

Pressure becomes infection and fibrosis

Unrelieved obstruction changes the liver from a biochemical problem to a structural one.

Outflow resistance raises intraductal pressure, retains bile acids and conjugated bilirubin, and produces canalicular and ductular cholestasis.

Stasis permits bacterial ascent and reduces clearance, so obstruction plus infection can become acute cholangitis, bacteremia, and organ failure.

Persistent obstruction drives portal edema, ductular reaction, biliary interface injury, and periportal fibrosis that can progress to secondary biliary cirrhosis; the tempo varies with completeness, cause, and infection.

Stones, scars, and tumors obstruct differently

Tempo and anatomy narrow the cause before a scope enters the duct.

Choledocholithiasis often causes abrupt pain and fluctuating obstruction, although a stone can also produce sustained jaundice or pancreatitis.

Benign strictures follow bile duct surgery, transplantation, pancreatitis, ischemia, or chronic inflammation and may present with recurrent cholangitis or slowly progressive cholestasis.

Pancreatic head, ampullary, gallbladder, and bile duct malignancies more often cause progressive obstruction, weight loss, and painless jaundice, but symptoms overlap enough that imaging and tissue may be required.

A stone moves, a scar narrows, and a tumor progresses, but imaging must prove the story.

Read the labs with the vital signs

A cholestatic panel localizes the process; fever and organ dysfunction determine urgency.

Mechanical obstruction usually raises alkaline phosphatase and GGT out of proportion to AST and ALT, with conjugated hyperbilirubinemia, dark urine, and pale stools when obstruction is substantial.

A transient common duct stone can briefly produce a sharp aminotransferase spike, so one early panel does not exclude obstruction.

Fever, right upper quadrant pain, jaundice, hypotension, altered mental status, kidney injury, hypoxemia, coagulopathy, or thrombocytopenia raise concern for infected obstruction and urgent source control.

Let physiology set the decompression clock

Duct size supports obstruction, but organ dysfunction sets emergency priority.

A dilated duct increases suspicion but is not required early in obstruction, and age, prior cholecystectomy, chronicity, and anatomy affect the expected caliber.

Stable obstruction without infection permits deliberate mapping, while systemic inflammation plus cholestasis and imaging evidence supports cholangitis and accelerates drainage.

Shock, altered mental status, kidney injury, respiratory failure, coagulopathy, or thrombocytopenia indicate organ dysfunction and demand immediate resuscitation with urgent source control.

Decompress the right patient at the right speed

Treatment must address both the obstruction and its cause.

Suspected cholangitis requires prompt fluids, cultures when feasible, and antibiotics active against likely enteric organisms, adjusted for severity, health-care exposure, local resistance, allergy, and renal function.

ERCP is generally preferred for accessible acute biliary decompression; percutaneous drainage or surgery is used when endoscopic access fails, anatomy is altered, or another route is safer.

Stable malignant obstruction needs coordinated tissue diagnosis, staging, resectability assessment, and a drainage plan that does not compromise definitive surgery; not every jaundiced patient should receive an unplanned stent.